These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 4647829)

  • 1. Experimental diabetic retinopathy.
    Patz A
    Isr J Med Sci; 1972; 8(8):1630-1. PubMed ID: 4647829
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental diabetic retinopathy.
    Leuenberger PM; Beauchemin ML; Babel J
    Arch Ophtalmol Rev Gen Ophtalmol; 1974 Apr; 34(4):289-302. PubMed ID: 4277478
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental diabetic retinopathy in the rat].
    Babel J; Leuenberger P; Cameron D; Renold A
    Mod Probl Ophthalmol; 1972; 10():577-86. PubMed ID: 4341410
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic retinopathy: galactose-fed rat model.
    Robison WG
    Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):4A, 1743-4. PubMed ID: 7635650
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on retinal neovascularization.
    Patz A
    Trans New Orleans Acad Ophthalmol; 1983; 31():82-8. PubMed ID: 6194596
    [No Abstract]   [Full Text] [Related]  

  • 6. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus.
    Hainsworth DP; Katz ML; Sanders DA; Sanders DN; Wright EJ; Sturek M
    Comp Med; 2002 Dec; 52(6):523-9. PubMed ID: 12540165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
    Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
    J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models and their use in studies of diabetic retinal microangiopathy.
    Bazan NG; Gordon WC; Marcheselli VL; Lukiw WJ; Duhault J; Koenig-Berard E; Linn DM; DeCoster MA; Mukherjee PK
    Therapie; 1997; 52(5):447-51. PubMed ID: 9501573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The experimental study of captopril and valsartan on the preventing and treatment of diabetic retinopathy in diabetic mice].
    Xie XW; Zhao P
    Zhonghua Yan Ke Za Zhi; 2004 Nov; 40(11):770-3. PubMed ID: 15634486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic angiopathy: new experimental and clinical aspects.
    Flyvbjerg A; Orskov H
    Horm Metab Res; 2005 Apr; 37 Suppl 1():1-3. PubMed ID: 15918103
    [No Abstract]   [Full Text] [Related]  

  • 11. Human and experimental retinopathy in the rat. Study on flat retinal preparations.
    Duhault J; Lebon F
    Arzneimittelforschung; 1972 Oct; 22(10):1695-7. PubMed ID: 4677059
    [No Abstract]   [Full Text] [Related]  

  • 12. KK mice as a model of microangiopathic lesions in diabetes.
    Duhault J; Lebon F; Boulanger M
    Bibl Anat; 1973; 11():453-8. PubMed ID: 4789080
    [No Abstract]   [Full Text] [Related]  

  • 13. Proteomics and diabetic retinopathy.
    Merchant ML; Klein JB
    Clin Lab Med; 2009 Mar; 29(1):139-49. PubMed ID: 19389556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy.
    Bloomgarden ZT
    Diabetes Care; 2008 May; 31(5):1080-3. PubMed ID: 18445731
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy.
    Cohen MP; Hud E; Shea E; Shearman CW
    Ophthalmic Res; 2008; 40(1):5-9. PubMed ID: 18025835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice.
    Goto H; Nishikawa T; Sonoda K; Kondo T; Kukidome D; Fujisawa K; Yamashiro T; Motoshima H; Matsumura T; Tsuruzoe K; Araki E
    Biochem Biophys Res Commun; 2008 Feb; 366(3):814-20. PubMed ID: 18083119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin may cause deterioration of proliferative diabetic retinopathy.
    Zhang P; Liu N; Wang Y
    Med Hypotheses; 2009 Mar; 72(3):306-8. PubMed ID: 19027244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy.
    Sennlaub F; Valamanesh F; Vazquez-Tello A; El-Asrar AM; Checchin D; Brault S; Gobeil F; Beauchamp MH; Mwaikambo B; Courtois Y; Geboes K; Varma DR; Lachapelle P; Ong H; Behar-Cohen F; Chemtob S
    Circulation; 2003 Jul; 108(2):198-204. PubMed ID: 12821538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG; Laver NM; Jacot JL; Glover JP
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy screening.
    Stefánsson E
    Pediatrics; 2006 Feb; 117(2):586; author reply 586-7. PubMed ID: 16452386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.